# 5-Azacytidine With Steroids for Gastrointestinal GVHD (5-AZA FOR GVHD)

> **NCT06598332** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Baylor College of Medicine**

## Conditions studied

- Graft-Versus-Host Disease(GVHD)

## Interventions

- **DRUG:** 5-Azacytidine

## Key facts

- **NCT ID:** NCT06598332
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-08
- **Primary completion:** 2028-05-01
- **Final completion:** 2029-05-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There is no funding.
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06598332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06598332, "5-Azacytidine With Steroids for Gastrointestinal GVHD (5-AZA FOR GVHD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06598332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*